A Prospective, Open-ended, Multi-center Study of Schizophrenia Patients Switching to Zolodine

NCT04975035 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Zolodine

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University